Please login to the form below
EFPIA hires director of European affairs
Elizabeth Kuiper will join trade body on May 1
The appointment, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), is part of ongoing efforts to improve the organisation's service to EU-level policymakers and better represent its members.
Kuiper is currently an attachée at the Permanent Representation of the Netherlands to the EU, where she represents the Netherlands in EU negotiations in the field of health, pharmaceuticals and medical devices.
Previously an adviser to the Dutch minister of health, welfare and sports, Kuiper has an MA in Dutch language and literature from the University of Utrecht.
Kuiper's arrival at EFPIA will be closely followed by that of recently appointed communications director Liam English, who joins from Lilly.
He will be responsible for developing EFPIA's communications strategy and overseeing the organisation's reputation management.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
